Shuttle Pharmaceuticals Enters Material Definitive Agreement
Ticker: SHPH · Form: 8-K · Filed: Feb 27, 2025 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, filing-update
TL;DR
Shuttle Pharma signed a big deal on 2/26/25. Details in new 8-K.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. entered into a material definitive agreement on February 26, 2025. The filing also includes financial statements and exhibits related to this agreement. The company is incorporated in Delaware and its principal executive offices are located in Gaithersburg, MD.
Why It Matters
This filing indicates a significant new contract or partnership for Shuttle Pharmaceuticals, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new opportunities but also new risks and obligations for a company.
Key Numbers
- 001-41488 — SEC File Number (Identifies the company's filing history with the SEC.)
- 82-5089826 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- February 26, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, MD (location) — Address of principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by Shuttle Pharmaceuticals?
The filing states that Shuttle Pharmaceuticals Holdings, Inc. entered into a material definitive agreement on February 26, 2025, but the specific details of the agreement are not provided in this excerpt.
When was the report filed with the SEC?
The report was filed as of date February 27, 2025.
What is Shuttle Pharmaceuticals' primary business?
Shuttle Pharmaceuticals Holdings, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
Where are Shuttle Pharmaceuticals' principal executive offices located?
The principal executive offices are located at 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 regarding Shuttle Pharmaceuticals Holdings, Inc. (SHPH).